Furthermore, LPC(14:0) concentration can discriminate between patients with DILD and those with LuCa, IIP, CTD, COPD, and BrAs, exceeding the performance of KL-6 and SP-D biomarkers in LuCa, IIP, and CTD cases. Here, MUC1 is linked to chronic obstructive pulmonary disease.